The stock of Motus GI Holdings Inc (NASDAQ:MOTS) registered an increase of 31.54% in short interest. MOTS’s total short interest was 515,500 shares in March as published by FINRA. Its up 31.54% from 391,900 shares, reported previously. With 31,600 shares average volume, it will take short sellers 16 days to cover their MOTS’s short positions. The short interest to Motus GI Holdings Inc’s float is 8.49%.
It closed at $4.29 lastly. It is down 17.78% since March 17, 2018 and is downtrending. It has underperformed by 22.15% the S&P500.
Motus GI Holdings, Inc., a medical technology company, focuses on the development and commercialization of the Pure-Vu System. The company has market cap of $91.98 million. The Company’s Pure-Vu System is designed to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. It currently has negative earnings.
More notable recent Motus GI Holdings, Inc. (NASDAQ:MOTS) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare – Seeking Alpha” on March 12, 2018, also Fool.com with their article: “Better Buy: DocuSign vs. Upwork – The Motley Fool” published on November 20, 2018, Nasdaq.com published: “Motus GI decreases proposed IPO deal size to $21 million ahead of tonight’s IPO – Nasdaq” on February 13, 2018. More interesting news about Motus GI Holdings, Inc. (NASDAQ:MOTS) were released by: Seekingalpha.com and their article: “Motus GI launches stock offering – Seeking Alpha” published on December 17, 2018 as well as Businesswire.com‘s news article titled: “Motus GI Announces Successful Clinical Use of Pure-Vu® Slim Sleeve with Slim Colonoscopes – Business Wire” with publication date: November 08, 2018.